英文标题：ADMET-EvO: a self-evolving scientific agent for sustained research across heterogeneous tasks
作者：Yiling Zhou, Yilin Wang, Jianmin Wang, Heqin Zhu, Zirui Wang, Chang-yu Hiesh, Kejun Ying, Jiaqi Wang, Yuzhi Xu, Tingjun Hou, Odin Zhang
arXiv ID：2609.10121 | 分类：q-bio.QM | 发表：2026-09-10
许可：CC-BY
摘要 科学智能体能够超越自动化模型构建，利用积累的证据来修正其研究问题与实验策略。挑战在于如何在异构任务间维持这种适应性，同时避免决策对内部验证集的过拟合。吸收、分布、代谢、排泄与毒性（ADMET）预测提供了一个涵盖多样检测、数据集与化学领域的严苛场景。为此，我们开发了 ADMET-EvO，一种证据门控智能体，它形式化端点定义、生成可证伪假设，并在数据、特征与模型轴上检验干预措施。它将支持、拒绝与不确定的结果向前传递，以指导每一个新的循环。在包含 22 项任务的 Therapeutics Data Commons（TDC）ADMET 基准上，ADMET-EvO 取得了最高的任务归一化分数 96
Scientific agents can move beyond automated model building by using accumulated evidence to revise both their questions and experimental strategies. The challenge is sustaining this adaptation across heterogeneous tasks without overfitting decisions to internal validation. Absorption, distribution, metabolism, excretion and toxicity (ADMET) prediction provides a demanding setting across diverse assays, datasets and chemical domains. We therefore developed ADMET-EvO, an evidence-gated agent that formalizes endpoints, generates falsifiable hypotheses and tests interventions across data, feature and model axes. It carries supported, rejected and inconclusive outcomes forward to guide each new cycle. Across the 22-task Therapeutics Data Commons (TDC) ADMET benchmark, ADMET-EvO achieved the highest task-normalized score of 96.77. Evidence-guided selection reduced cumulative fitting time by 72.2% within a predefined non-inferiority margin. It also formalized 43 toxicity-related tasks and constructed endpoint-specific predictors. Together, these results show how ADMET-EvO can accumulate evidence, revise its strategy and expand its research scope over time.
查看完整双语翻译 →
正在跳转到翻译阅读页… 如果没有自动跳转，请点击这里。